Indee Labs
Enabling T cell immunotherapy discovery, development and manufacturing
About
Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.
Topics
- Location
- San Francisco, CA, United States
- Team size
- 5 employees
- YC batch
- Winter 2017
- Status
- Active
- Stage
- Early stage
